Vedana Therapeutics emerged from stealth with a $46M Series A. Led by local biotech veterans, the Seattle startup is developing next-gen, at-home migraine injections. Read More
OceanGate, the maker of deep-sea submersibles, hired Robert Shuman as chief operating officer. Shuman previously held senior business roles at… Read More
Carlos Campoy is the new CFO at Alder BioPharmaceuticals. The Bothell, Wash.-based drug company is developing eptinezumab, an antibody-based migraine… Read More
Shares of Alder BioPharmaceuticals continue to fall after the company received notice from partner Bristol-Myers Squibb Company after the giant drug company… Read More
